BTLA
BTLA or B and T Lymphocyte Attenuator is a protein that in humans is encoded by the BTLA gene. BTLA is a member of the immunoglobulin superfamily and is expressed on T-lymphocytes, B-lymphocytes, and other immune cells. It functions as an immune checkpoint and plays a crucial role in the regulation of immune responses.
Structure[edit | edit source]
BTLA is a type I transmembrane protein with an extracellular immunoglobulin domain. The extracellular domain of BTLA interacts with its ligand, herpesvirus entry mediator (HVEM), a member of the tumor necrosis factor receptor superfamily.
Function[edit | edit source]
BTLA serves as a negative regulator of the immune response. Upon binding to HVEM, BTLA inhibits T-cell activation, proliferation, and cytokine production, thereby preventing excessive immune responses and maintaining immune homeostasis. BTLA also plays a role in the development and function of regulatory T cells, which further contributes to immune regulation.
Clinical significance[edit | edit source]
Alterations in the BTLA-HVEM pathway have been implicated in various diseases, including autoimmune diseases, infectious diseases, and cancer. In cancer, BTLA is often upregulated on tumor-infiltrating lymphocytes, and its interaction with HVEM can contribute to immune evasion by the tumor. Therefore, targeting the BTLA-HVEM pathway is being explored as a potential strategy for cancer immunotherapy.
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD